Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor
申请人:AstraZeneca AB
公开号:US07332492B2
公开(公告)日:2008-02-19
Compounds of formula (I):
wherein:
X is a group of formula (B):
and R1, R2, R4, n, x, y and z are as defined within are described.
Processes for their preparation and their use in the treatment of disorders mediated by the neuropeptide Y5 receptor in a warm-blooded animal, such as a human being, are also described.
AMINO SUBSTITUTED DIBENZOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS MEDIATED BY THE NP Y5 RECEPTOR
申请人:AstraZeneca AB
公开号:EP1278739A1
公开(公告)日:2003-01-29
US6967216B2
申请人:——
公开号:US6967216B2
公开(公告)日:2005-11-22
US7332492B2
申请人:——
公开号:US7332492B2
公开(公告)日:2008-02-19
[EN] AMINO SUBSTITUTED DIBENZOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS MEDIATED BY THE NP Y5 RECEPTOR<br/>[FR] DERIVES DE DIBENZOTHIOPHENE AMINO SUBSTITUTES DESTINES AU TRAITEMENT DE TROUBLES INDUITS PAR LE RECEPTEUR DU NEUROPEPTIDE Y5
申请人:ASTRAZENECA AB
公开号:WO2001085714A1
公开(公告)日:2001-11-15
Compounds of formula (I), wherein X is a group of formula (A) or (B) and R?1, R2, R3, R4¿, n, x, y and z are defined within are described. Processes for their preparation and their use in the treatment of disorders mediated by the neuropeptide Y5 receptor in a warm-blooded animal, such as a human being are also described.